Exploration on the Interaction Ability of Antitumor Compound Bis-[2,6-difluoro-<i>N</i>-(hydroxyl-<κ><i>O</i>)benzamidato-<κ><i>O</i>]dibutylitin(IV) with Human Peroxisome Proliferator-Activated Receptor hPPAR<i>γ</i>

<div>Stern–Volmer plots of hPPAR<i>γ</i> interacted with DBDF2,6T at different temperatures.</div>

Bioinorganic Chemistry and Applications

fig3

Figure 3

Figure 3: Exploration on the Interaction Ability of Antitumor Compound Bis-[2,6-difluoro-<i>N</i>-(hydroxyl-<κ><i>O</i>)benzamidato-<κ><i>O</i>]dibutylitin(IV) with Human Peroxisome Proliferator-Activated Receptor hPPAR<i>γ</i> 

Figure 3 | Exploration on the Interaction Ability of Antitumor Compound Bis-[2,6-difluoro-N-(hydroxyl-O)benzamidato-O]dibutylitin(IV) with Human Peroxisome Proliferator-Activated Receptor hPPARγ 

Bioinorganic Chemistry and Applications

Exploration on the Interaction Ability of Antitumor Compound Bis-[2,6-difluoro-N-(hydroxyl-<κ>O)benzamidato-<κ>O]dibutylitin(IV) with Human Peroxisome Proliferator-Activated Receptor hPPARγ

Figure 3